Skip to main content

Table 3 Results of transbronchial lung biopsy, bronchial lavage and BAL

From: Diagnostic yield, safety, and impact of transbronchial lung biopsy in mechanically ventilated, critically ill patients: a retrospective study

Specimen

n (%)

Transbronchial lung biopsy

42

Organizing pneumonia

23 (54.8)

Diffuse alveolar damage

4 (9.5)

Drug-induced lung toxicity

4 (9.5)

Purulent bronchopneumonia

2 (4.8)

Acute exacerbation of ILD

1 (2.4)

Granulomatous disease (Tb)

1 (2.4)

Non-small cell lung cancer

1 (2.4)

Silicosis

1 (2.4)

Bronchial lavage

41

Cytomegalovirus (PCR)

3

Pseudomonas aeruginosa (culture)

3

Herpes simplex virus (PCR)

1

Aspergillus fumigatus (culture)

1

Klebsiella oxytoca (culture)

1

Stenotrophomonas maltophilia (culture)

1

Enterococcus faecalis (culture)

1

Pneumocystis jiroveci (PCR)

1

Mycobacterium tuberculosis (culture)

1

Broncho-alveolar lavage (BAL)

21

Neutrophilia

13 (61.9%)

Neutrophilia, Eosinophilia

3 (14.3%)

Neutrophilia, Eosinophilia, Lymphocytosis

2 (9.5%)

Neutrophilia, Lymphocytosis

1 (4.8%)

Lymphocytosis

1 (4.8%)

Normal cell distribution

1 (4.8%)

  1. Normal cell distribution of BAL refers to ≥85% of alveolar macrophages, ≤ 15% lymphocytes, ≤ 3% neutrophils, and ≤ 1% eosinophils
  2. Abbreviations: OP organizing pneumonia, ILD interstitial lung disease, Tb tuberculosis, PCR polymerase chain reaction